SCHEMBL29242634

SCHEMBL29242634

CNC(=O)c1cc(Oc2ccc(C(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 15/20 0.84
BRAF P15056 8/20 0.84
KDR P35968 6/20 0.84
RET P07949 3/20 0.84
RIPK2 O43353 2/20 0.84
ABCB11 O95342 2/20 0.84
ABL1 P00519 2/20 0.84
HTR1A P08908 2/20 0.84
PDGFRB P09619 2/20 0.84
ADORA3 P0DMS8 2/20 0.84
KIT P10721 2/20 0.84
FGFR1 P11362 2/20 0.84
PDGFRA P16234 2/20 0.84
FLT1 P17948 2/20 0.84
MAOA P21397 2/20 0.84
EPHA1 P21709 2/20 0.84
TBXA2R P21731 2/20 0.84
EPHA2 P29317 2/20 0.84
TTK P33981 2/20 0.84
EPHX2 P34913 2/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16628076 0.94 RAF1 (0.81) RAF1BRAFKDRRETRIPK2
SCHEMBL10199708 0.92 RAF1 (0.74) RAF1BRAFKDRRETRIPK2
SCHEMBL6030121 0.91 RAF1 (0.89) RAF1BRAFKDRRETRIPK2
Sorafenib SCHEMBL8218 0.91 RAF1 (1.00) RAF1BRAFKDRRETRIPK2
Sorafenib SCHEMBL14739751 0.91 RAF1 (1.00) RAF1BRAFKDRRETRIPK2
Sorafenib SCHEMBL29349634 0.91 RAF1 (1.00) RAF1BRAFKDRRETRIPK2
Sorafenib SCHEMBL1533976 0.90 RAF1 (0.98) RAF1BRAFKDRRETRIPK2
Sorafenib SCHEMBL1533982 0.90 RAF1 (0.98) RAF1BRAFKDRRETRIPK2
Sorafenib SCHEMBL1896610 0.90 RAF1 (0.98) RAF1BRAFKDRRETRIPK2
Sorafenib SCHEMBL18863920 0.90 RAF1 (0.98) RAF1BRAFKDRRETRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121102253-A Pharmaceutical composition containing saikosaponin B2 and sorafenib and application thereof 浙江中医药大学 2025-12-12 CN disclosed
CN-119925616-A CD20 therapy, CD22 therapy and combination therapy with CD19 Chimeric Antigen Receptor (CAR) expressing cells 诺华股份有限公司 2025-05-06 CN disclosed
CN-118234496-A Improved treatment of advanced/metastatic cancers with checkpoint inhibitor resistance or drug resistance susceptibility 海南先声再明医药股份有限公司 2024-06-21 CN disclosed
CN-117866991-A Chimeric antigen receptor for the treatment of cancer 诺华股份有限公司 2024-04-12 CN disclosed
CN-110225927-B Chimeric antigen receptor for the treatment of cancer 诺华股份有限公司 2024-01-12 CN disclosed